FDA Inspection 1295872 — Michal Krawczynski, MD
The FDA completed an inspection of Michal Krawczynski, MD on November 21, 2025 in Poznan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Poznan (Poland)
Additional Details
Clinical Investigator (CI)